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Anti-prostasome autoantibodies in serum from 
prostate cancer patients 
K.G. RONQUIST, L. CARLSSON, G. RONQUIST, 
L. LARSSON 
Department of Medical Sciences, Sweden 
Email : goran.ronquist@medscLuu.se 
Objectives : Prostasomes are secretory granules 
synthesized, stored and released by normal and neoplastic 
human prostate epithelial cells. The average size is 150 nm 
in diameter (range 50-500 nm) and the bilayered membrane 
has a very high cholesterol/phosphotipid ratio making up an 
interesting new biological environment. Prostasomes seem 
to have several important functions in the reproduction 
process. Prostasomes escaping from the urogenital tract 
mount an immune response against themselves. Other cell 
types have also been proved toproduce extracellular vesicles 
in a similar way called exosomes. Each vesicle type has a 
unique membrane protein composition reflecting the cell 
from which it originates. The aim with this study was to 
identify the prostasome-derived proteins that were 
immunogenic in serum from prostate cancer patients. 
Materials and Methods : The aim was to identify the 
prostasome-derived proteins that were immunogenic in 
prostate cancer patients. Prostate cancer patients' sera (n 
= 44) with high enzyme-linked immunosorbent assay (ELISA) 
titers against prostasomes were selected for immunoblotting 
against purified seminal prostasomes separated on 2D gels. 
Twenty-five of the recognized proteins were isolated and 
analyzed by means of mass spectrometry. 
Results : Out of 44 patients' sera, 31 (70%) demonstrated 
in immunoblotting experiments reactivity against several 
prostasomal protein bands in the molecular weight range of 
10-200 kDa. Some of the bands (55, 70 and 170 kDa) were 
more frequently recognized by the patients' sera. 
Concomitantly run control sera generated only very weak or 
no bands at all. The most frequently occurring prostasomal 
proteins were identified as heat shock proteins (HSP 70, 
71) and clusterin. 
Conclusion : Prostate cancer consistently remains a difficult 
clinical enigma. Therefore, the development of novel 
strategies for diagnosis and treatment (e.g. immunotherapy) 
of prostate cancer is essential. This study identified the most 
important molecular targets of autoantibodies against 
prostasomes generated in connection with the development 
of prostate cancer in man. These immunogenic prostasomal 
proteins could be appropriate target molecules for specific 
immunotherapy of prostate cancer patients. 
OR 02 
Prospective multicenter study on safety and 
efficacy of intramuscular injections of 1000 mg 
testosterone undecanoate in hypogonadal men 
under conditions resembling real-life 
H.M. BEHRE1, J. ELLIESEN2, AND THE 
TESTOSTERONE UNDECANOATE STUDY GROUP 
1 Andrology Unit, Dept. of Urology, Martin-Luther- 
University, Halle, Germany;2 Schering AG, Berlin, 
Germany 
Objective : The study was performed to evaluate 
intramuscular testosterone undecanoate (TU) for treatment 
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of hypogonadal men under conditions which resemble real- 
life situations as closely as possible (e.g., variable injection 
intervals, minimum selection of patients, i.e., including 
hypogonadal patients with co-morbidities). Itwas intended to 
test the safety profile of TU under long-term treatment with 
respect to serum levels of prostate-specific antigen (PSA) 
[primary study variable], prostate size measured by transrectal 
ultrasonography, physical examinations and standard safety 
laboratory. A further aim was to demonstrate that sustained 
serum testosterone (T) levels in the physiological range can 
be retained under real-life conditions, preserving satisfaction 
with the treatment. 
Design : Open-label, prospective, multicenter (16 centers in 
Germany), one-arm study. 
Material and Methods : Men with hypogonadism, aged 18 
- 75 years, with serum total T levels < 10 nmol/I and no 
contraindications for T therapy were included. 1000 mg TU 
(Nebido| were given at individually adjustable loading 
intervals of 6 - 10 weeks between the first 2 injections and 
maintaining intervals of 10 - 14 weeks (total: 6 TU injections). 
Results : Of 161 patients creened, 96 could be included (age, 
48.6 + 12.7 years [mean + SD]; height, 178.85 + 7.84 cm; body 
weight, 93.33 + 15.71 kg; body mass index, 29.22 + 4.80 
kg/m2). Trough concentrations of total T (considered as an 
indicator of the adequacy of substitution) increased from 5.60 
+ 3.03 nmol/I at baseline to levels between 9.79 + 3.96 and 
14.02 + 6.06 nmol/I in the course of treatment phase. Median 
values of trough T after the 2nd TU injection were 12 - 13.25 
nmol/l. Mean PSA serum concentration of 0.81 + 0.80 ng/ml 
at screening moderately increased to 1.23 + 1.33 ng/ml after 
the 6th TU injection. At the time of the 5th TU injection, 75% 
of the patients had PSA values < 1.40 ng/ml (3 rd quartile) ; 
at the time of the final examination the 3rd quartile was 
1.5 ng/ml. There were 7 patients with elevated PSA values 
above the age-specific normal range at the final examination 
compared to 1 patient at screening; however, only 2 of them 
had values within the age-specific alert ranges. Malignant 
changes were excluded by prostate biopsies in 4 patients 
with a PSA level above 4 ng/ml. Mean prostate volume 
increased from 20.66 + 11.44 ml at screening to 22.54 + 13.11 
ml at the time of the 5th injection and 22.63 + 12.84 ml at the 
final examination. Physical examinations and standard safety 
laboratory confirmed the safety of TU. 92.5% of the patients 
assessed the treatment with TU as satisfying. Of them 40.4% 
were "very much satisfied" and 43.6% "much satisfied". 
Conclusions : Under conditions resembling real-life situations, 
intramuscularTU (Nebido~) appears to be a safe and efficient 
drug for treatment of male hypogonadism. The majority of 
patients express high satisfaction with the treatment. 
Support : The study was supported by Schering AG, Germany. 
OR 03 
Androgens modulate the availability of active 
glucocorticoids by regulating 11-SS-HSD1 activity 
in murine adipocytes in vitro 
A.M. ISIDORI, S. PIEROTTI, D. GIANFRILLI, 
E. GIANNETTA, V. BONIFACIO AND A. LENZI 
Cattedra di Endocrinologia, Dipt. Di Fisiopatologia Medica, 
Univ. "La Sapienza" di Roma. 
Objective : In humans, testosterone treatment affects body 
fat distribution and metabolism. The mechanisms involved 
in these processes are not yet entirely understood. We 
hypothesized that sex hormones modulate the activity of [type 
1] 11-6-hydroxy-steroid-dehydrogenase (11-HSD1) -the 
enzyme involved in the intracellular activation of 
glucocorticoids. 
Design : We measured intracellular fat accumulation, leptin 
production (Lep) and 11-HSD1 activity in differentiating or 
fully mature 3T3-L1 cells under the conditioning effects of 
sex hormones. 
Materials and Methods : 11-HSD1 activity was estimated 
calculating the molar conversion of [H3]-dehydrocorticosterone 
(DHC) into [H3]-corticosterone. Steroids were extracted using 
solvents, separated by TLC and measured by I~-scanning of 
the TLC plate. Testosterone (T), DHT and estradiol (E2), in 
the presence/absence of androgen receptor antagonist 
(flutamide) and aromatase inhibitor (formestane) were tested 
at various time-points (2 to 6 days) and doses (1 nmol to 1 
tJmol/L) using carchoal-stripped serum and/or minimum serum- 
free cell cultures. Various treatment condition using a synthetic 
Liver X Receptor (LXR) Agonist were also tested. 
Results : We found that 3T3-L1 cells acquire 11-HSD1 activity 
at early stages of differentiation and that the activity increases 
steadily during differentiation i  parallel with fat accumulation. 
We demonstrated that androgens (T and DHT) enhance 11- 
HSD1 activity dose-dependently either in mature and 
differentiating cells (form 10% when treated with 1 nM T, to 
40% with 1 IJM T ; conversion measured at 90 minutes 
incubation with 15 nM [H3]-DHC + 15 nM cold-DHC). We 
also showed that androgen modulation of enzymatic activity 
was similar to that achieved by insulin (5 ng/ml) -a known 
regulator of 11-HSDI. Conversely, LXR agonist inhibited 11- 
HSD1 activity dose-dependently. We also found that the effect 
of androgens, but not insulin, were partially blunted by pre- 
treatment with flutamide (200 nM). In addition, we showed that 
T treatment on differentiating cells, inhibited leptin production 
and fat accumulation/release while increasing 11-HSD1 activity. 
The latter finding suggests that the effects of androgens on 
the enzyme were independent of their effects on differentiation 
and fat storage. 
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Conclusions : In summary, we showed that in an experimental 
murine model androgens may regulate adipocytes metabolism 
by affecting the availability of intracellular glucocorticoids. 
The implication of these findings on testosterone replacement 
therapy remains to be established with human models and 
in vivo studies. 
OR 04 
0.01-100nM) stimulated gene expression of both KISS-1 and 
GPR54. In addition, we found that leptin (tnM), an adypocyte- 
derived hormone known to act on the hypothalamus to 
influence reproduction, increased the expression of KISS-1 
and GPR54 mRNAs. 
Conclusions : Overall, our results indicate that FNCB4 cells 
represent a valuable tool to study in vitro the regulation of KISS- 
1/GPR54 system in order to identify those permissive signals 
that determine the precise timing of puberty onset and related 
disorders. 
Sex steroid regulation of kisseptin/GPR54 
system, a new regulator of the neuroendocrine 
reproductive axis, in human fetal GnRH secreting 
neurons 
A. MORELLI1, R. MANCINA 1, L. VIGNOZZI1, 
M. LUCONI 2, G. FORTI 1, M. MAGGI1 
1 Andrology and 2 Endocrinology Units, Department of 
Clinical Physiopathology ; 3 Department of Anatomy, 
Histology and Forensic Medicine, University of Florence, 
Florence, Italy (a.morelli@dfc.unifi.it) 
Objective : The hypothalamic GnRH neurons, arising from 
the olfactory placode region, remain immature until puberty. 
The molecular mechanisms underlying their reawakening at 
puberty remain to be completely elucidated. Recently, the G 
protein-coupled receptor 54 (GPR54) and its endogenous 
ligand kisspeptin, encoded by the KISS-1 gene, have been 
crucially involved in the hypothalamic mechanisms that time 
puberty. We used the previously characterized human fetal 
olfactory GnRH-secreting neurons, FNC-B4, in order to study 
the KISS-1/GPR54 system. 
Design and Methods : FNC-B4 are immature neurons that 
can differentiate in vitro and express both neural and olfactory 
markers. Moreover, these cells express and release GnRH 
in response to sex steroids and odorants, as well as migrate 
in response to GnRH and endothelin-l. By real-time RT-PCR 
and western blot analysis we studied the kisspeptin and 
GPR54 expression in FNC-B4 in response to sex steroids 
stimulation. 
Results : We report that these human neuronal precursor cells 
express both gene and protein of kisspeptin and GPR54. 
With immunohistochemistry we localized both kisspeptin and 
GPR54 in sections of fetal olfactory mucosa, as well as in FNC- 
B4 cells. Moreover, we observed that sex steroids regulated 
both gene and protein expression of KISS-1/GPR54 system. 
In particular, we found that increasing concentrations (0.01- 
100nM) of 17beta-estradiol significantly decreased 
(IC50=0.3nM) in a dose-dependent manner the amounts of 
KISS-1 and GPR54 mRNA. Conversely, androgens (DHT, 
OR 05 
Inhibition of Phosphodiesterase type 5 is 
associated to an in vivo and in vitro improved 
activity of circulating angiogenic cells in men 
with erectile dysfunction 
S. FRANCAVILLA1, M. BOCCHIO 1, F. PELLICCIONE 1, 
G. PASSAQUALE2, S. NECOZlONE3, C. FERRI2 
Chairs of 1 Andro/ogy, 2/ntema/Medicine, 3 Epidemio/ogy, 
University of L'Aqui/a, /ta/y. Presenting author e-mail : 
HYPERL/NK "mai/to : sandrof@univaq.it" 
sandrof@univaq.it 
Objective : Circulating angiogenic cells (CACs) contribute to 
repair of the vessel wall and dysfunctional CACs are associated 
to endothelial dysfunction in men with vascular risk factors 
(VRFs). 
Design : We investigated whether inhibition of 
phosphodiesterase type 5 (PDE5) in men with erectile 
dysfunction (ED) and VRFs is accompanied to changes of 
activity of CACs. 
Materials and Methods : Thirty six men with ED and VRFs 
were randomised to 4 weeks of tadalafil (20 mg/other day) or 
placebo treatment. The number of ex vivo expanded functional 
CACs, identified by uptake of 1,1'-dioctadecyl-3, 3,3', 3'- 
tetramethylindocarbocyanine-labelled acetylated low-density 
lipoprotein (DiLDL) and concomitant Ulex europaeus agglutinin 
I (UEA-1) binding, was determined at baseline and after 
treatment. 
Results : The number of cells double-positive for DiLDL and 
for UEA-1, per high-power field fluorescence microscopy was 
significantly reduced in patients compared to 10 controls 
(26.88+6.3 and 74.41+17.1 respectively; P<0.0001) and was 
markedly increased after tadalafil treatment (40.69+13.07 
versus 25.82+6.49; P<0.0001) but not after placebo. The 
percentage variation of the number of CACs was correlated 
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with the percent change of Flow-mediated dilation in the 
brachial artery by ultrasound, after treatment (R=0.59, 
P=0.0004). The migratory activity of ex vivo expanded CACs 
determined in a Boyden chamber system, was significantly 
increased after incubation for 3 hours with tadalafil (10-6M) 
(number of migrated cells:1073+363 versus 702+ 204; 
P=0.0007). The effect on number of cells after tadalafil 
incubation was not due to an increased proliferation of CACs. 
CACs proliferation was assessed by the incorporation into 
cellular DNA of 5-bromo-2'-deoxyuridine (BrdU) and 
subsequent staining with a TRITC-labelled mouse monoclonal 
antibody anti-BrdU. The number of BrdU-positive cells 
evaluated with an inverted fluorescence microscope did not 
change after 3 and 24 hours of tadalafil incubation (10-6M). 
Conclusion : In conclusion PDE5 inhibition has a beneficial 
in vivo and in vitro effect on vascular homeostasis by improving 
circulating angiogenic cell function. 
OR 06 
Testosterone regulates RhoAJRho-kinase 
signalling in two distinct animal models of 
chemical diabetes 
rabbit) and "in vivo" as erectile response elicited by electrical 
stimulation of cavernous nerve (diabetic rats). T-substitution 
(30 mg/kg, weekly) completely reverted hypogonadism and 
diabetes-induced penile hypersensitivity to Y27632. To test 
whether this effect was due to a T-dependent regulation of 
RhoA/ROK gene expression, we measured RhoA/ROK 
mRNA. Both isoforms of ROK (ROK1 and ROK2) were 
analyzed by real time RT-PCR in penile samples of each rat 
group. We found that ROK1 mRNAwas significant increased 
(p<0.05) in penile tissues from diabetic animals and restored 
to the control values by T, as also confirmed by semiquantitative 
RT-PCR in rabbit. Conversely, expression of RhoA and ROK2 
mRNAs was not influenced neither by diabetic condition and 
by T administration. Accordingly, ROK1 protein expression, 
as evaluated by western blot and immunohistochemistry 
analysis, resulted increased in penile samples from diabetic 
animals and normalized by T. 
Conclusions : Our data further support the hypothesis that 
the activation of RhoAJROK signalling contributes to diabetes- 
related erectile dysfunction. Moreover, treating hypogonadism 
in course of diabetes, may restore erectile function by 
maintaining a correct balance between pro-erectile NO/cGMP 
and anti-erectile RhoA/ROK pathways. 
OR 07 
L. VIGNOZZI1, A. MORELLI1, S. FILIPpI2, M. LUCONI3, 
G. FORTI1, M. MAGGI1 
1 Andro/ogy and 3 Endocrinology Units, Dept. of C/inica/ 
Physiopatho/ogy ; 2/nterdep. Lab of Functiona/ and 
Cellular Pharmacology of Reproduction, Depts. of 
Pharmacology and C/inica/ Physiopatho/ogy; University of 
Florence, Florence, /ta/y (/. vignozzi@dfc.unifi.it) 
Objectives : The RhoA/Rho-kinase (ROK) signalling pathway 
is up-regulated in erectile tissue of diabetes animal models 
and may contribute to diabetes-related erectile dysfunction 
(ED). In previous studies we demonstrated that testosterone 
(T) restores diabetes-induced ED by influencing the 
NO/cGMP/PDE5 pathway. The aim of our study was to 
investigate the effect of T on RhoA/ROK signalling in course 
of diabetes. 
Design and Methods : Two distinct animal models of chemical 
diabetes: alloxan-induced in the rabbit and streptozotocin- 
induced in the rat were used. 
Results : In both models, hypogonadism was observed, 
characterized by reduced T and atrophy of androgen- 
dependent accessory glands. Diabetic animals showed a 
significant increase in responsiveness to increasing 
concentrations of Y27632, a highly selective ROK inhibitor, 
as evaluated either by "in vitro" contractility study (diabetic 
Cryptorchidism and in utero exposure to 
endocrine disruptors in Nice area : absence of 
correlation between neonatal examination and 
concentrations of selected xenobiotics in cord 
blood and maternal milk 
F. BRUCKER-DAVIS 1-2, A. BONGAIN 3, B. DUCOT4, 
P. THONNEAU 5, K. WAGNER-MAHLER6, 
P. FENICHEL1-2 
1 Endocrinology Department, CHU Nice, 06200 Nice, 
France. 2 Unit# INSERM, Nice, France. 3 Gynaecology 
Department, CHU Nice, 06200 Nice, France. 4 Unit# 
INSERM, Paris, France. 5 CHU Toulouse, France. 6 
Pediatry Department, CHU Nice, Nice France 
Corresponding author : brucker-davis, f@chu-nice, fr 
The etiology of cryptorchidism, a frequent congenital 
malformation, is not completely elucidated, involving genetic 
and acquired factors. 
Objectives : We decided to test the hypothesis that 
environmental xenobiotics with hormonal action (endocrine 
disruptors) are involved. Data on in utero exposure are scarce 
in France. Thus, we realized a snapshot of in utero exposure 
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to selected xenobiotics in our area, looking for correlations with 
the testicular location at birth. 
Design : We have studied over 3 years (2002-2005) newborn 
boys born at 2 maternity wards (CHU Nice, and CHG Grasse), 
screening them for cryptorchidism and for exposure (cord 
blood and maternal milk) to selected xenobiotics known for 
their anti androgenic and/or estrogenic effects, tn addition, 
parents were asked to fill confidential questionnaires about 
their reproductive history, their origin, occupation, hobbies 
and other potential exposure. This study was funded as a 
PHRC 2001 and apporved by the Ethical board of our 
institutions. 
Material and methods : Of 6246 boys born at or after 34 
weeks, 101 were cryptorchid (incidence of 1.6% in Nice and 
Grasse). 95 were included in this study (48 from Nice and 47 
from Grasse), as well as 2 controls matched for gestationnal 
age, date and place of birth, and when possible ethnic origin. 
151 serum (67 cryptorchid and 84 controls) and 125 milk (56 
cryptorchid and 69 controls) were tested for the presence of 
7 non planar PCBs, DDE, dibutylphtalate and its metabolite 
monobutylphtalate, hexachlorobenzene, linuron, procymidone 
and vinclozolin. Xenobiotic measurements were performed by 
gaz chromatography coupled to mass spectometry at 
accredited laboratory (Laboratoire de I'Environnement de 
I'Agglomeration Nigoise). 
Results : All samples were positive for one or more xenobiotics 
confirming the ubiquitous exposure of foetuses/infants in our 
area. Concentrations were generally higher in milk, as expected 
for lipophilic compounds. Concentrations, however, were 
often lower than in other studies. We established scores of 
exposure (high, low, negligible) using composite scores 
including APCBs, DDE and phthalate. We have found no 
significant differences between cryptorchid and controls. As 
predictive factor of high exposure, we found maternal age, and 
for DDE, the geographical origin of the mother (subsaharian 
and north Africa). 
Conclusion : The incidence of cryptorchidism in our area is 
1.6% at birth. The exposure to endocrine disruptors is 
widespread, but at a lower level than in other reported series. 
Our current data does not support a direct link between 
exposure to a given xenobiotic and cryptorchidism in our 
population. 
OR 08 
Does histopathological tumor type or vascular 
invasion influence spermatogenesis in testicular 
cancer ? 
J.E. LACKNERa, A. KOLLER b, G. SCHATZLa, 
M. MARBERGERa, C. KRATZIK a 
Medica/ University of Vienna, Vienna, Austria 
a Department of Urology 
b Department of Pathology 
Objectives : To assess quality and activity of spermatogenesis 
in the contralateral testicle at the time of orchiectomy and to 
assess whether any tumor related factor such as tumor type 
or vascular invasion is a risk factor for impaired 
spermatogenesis. An additional aim was to investigate if 
areas with normal spermatogenesis for a possible harvesting 
of sperms for artificial reproductive technologies could be 
found in the contralateral testicle. 
Methods : Contralateral biopsy specimens at the time of 
unilateral orchiectomy from patients with testicular cancer 
were evaluated using the Johnsen score. Median and highest 
detectable Johnsen score were counted. The Johnsen score 
was correlated to histopathological tumor type such as 
seminoma and non seminomatous germ cell tumor (NSGCT) 
and to TNM stage. 
Results : From overall 76 patients 36 had a seminoma, while 
40 patients had a NSGCT. In all patients a stage I disease was 
diagnosed: in the seminoma group 13 pT1 and 23 pT2 tumors 
and in the NSGCT group 9 pT1, 29 pT2 and 2 pT3 tumors. 
The median Johnsen score of 8.9 in seminomas did not differ 
significant o that in NSGCT 8.6 (p=0.348). According to the 
presence of vascular invasion similar results were seen with 
a median Johnsen score of 8.8 (8.1-9.2) in pT1 and 8.8 (8.2- 
9.5) in pT2 or higher stages (p=0.389). Areas with a highest 
Johnsen score above 8 were found in 88.9% in seminomas 
and 92.5% in NSGCT. 
Conclusion : Testicular cancer is associated with impaired 
spermatogenesis. Neither the histopathological tumor type nor 
the presence of vascular invasion was correlated to significant 
reduced spermatogenesis. When testicular sperm extraction 
from contralateral testis at the time of orchiectomy is planned, 




Risk factors for development of hypogonadism in 
men treated for testicular cancer : 
a longitudinal study 
J. EBERHARD2, O. STAHL1-2, Y. GIWERCMAN2, 
E.C. SALMONSON3, A. RIGNELL-HYDBOM 4, 
A. GIWERCMAN2. 
Department of Oncology, Lund University Hospital, Lund 
University, Lund, Sweden. 
Fertility Centre, Scanian Andrology Centre, Maim6 
University Hospital, Lund University, Maim& Sweden. 
Department of Radiology, Lund University Hospital, Lund 
University, Lund, Sweden. 
Department of Environmental and Occupational Medicine, 
Lund University Hospital, Lund University, Lund, Sweden. 
and T60 (OR 4.4, 95% CI 1.2-16). Those hypogonadal at TO 
were at higher risk of hypogonadism at T6 (OR 53, 95% CI 
19-145), T12 (OR 125, 95% CI 37-430), T24 (OR 88, 95% CI 
26-300) and T36 (OR 121, 95% CI 32-460). We did not find 
any predictive value of age, stage of disease, AR 
polymorphisms, volume or consistency of contralateral testicle. 
Conclusion : Hypogonadism at TO together with type of 
treatment and microlithiasis of the contralateral testis seem 
to be predictive factors for post-treatment hypogonadism in 
men treated for TGCC. These risk factors should be taken into 
consideration in the clinical follow-up of men cured for testicular 
cancer. 
OR 10 
Increase in testicular cancer incidence in the 
Midi-Pyrenees region, France 
Background : TGCC (Testicular Germ Cell Cancer) patients 
have been suggested to be at risk of developing reduced 
Leydig cell function and hypogonadism because of both the 
disease per se and its treatment. The aim of current study was 
to define clinical and laboratory risk factors for developing 
hypogonadism in TGCC patients. 
Patients and Methods : During the period 2001-2005, 143 
consecutive TGCC patients followed at the oncological 
outpatient clinic, Lund University Hospital, were enrolled in the 
study. Blood samples were collected at fixed time points (after 
orchidectomy, prior to further therapy [TO] and 6, 12, 24, 36 
and 60 months IT6, T12, T24, T36, T60] after completion of 
therapy). Hypogonadism was defined as serum testosterone 
<10 nmol/L and/or LH>10 IU/L. Patients having increased 
hCG levels post-orchidectomy were not included. As possible 
predictive factors the following were tested: hypogonadism at 
TO (yes/no); age at diagnosis (<30/>30); type of treatment 
(adjuvant chemotherapy [ACT]/3-4 cycles chemotherapy 
[HCT]/adjuvant radiotherapy [RT]); stage of disease (I/11/111 
or IV); contralateral testicular microlithiasis on ultrasound 
(yes/no); testicular consistency (normal/abnormal); testicular 
volume (<15ml/>15ml); androgen receptor CAG and GGN 
repeat length. For each post-treatment time point, odds ratios 
for hypogonadism were calculated by use of binary logistic 
regression. As controls 104 Swedish fishermen aged 24-49 
years were used (median: 40 years). 
Results : As compared to controls, significantly increased 
odds ratios (OR) for hypogonadism was found at T6 (OR: 
5.3, 95% confidence interval [CI] 1.6-17) and T12 (OR 3.2, 
95% CI 1.1-9.3) in HCT treated men. Patients treated with ACT 
or RT did not have any higher risk of becoming hypogonadal 
than controls. Microlithiasis was predictive for hypogonadism 
atT0 (OR 11,95% CI 1.2-112), T12 (OR 3.9, 95% CI 1.1-13), 
T24 (OR 3.0, 95% CI 1.0-8.8), T36 (OR 5.4, 95% CI 1.7-17) 
M. WALSCHAERTS 1-4, E. HUYGHE 1"2, R. MIEUSSET1, 
M. DAUDIN1-3, P. PLANTE1-2, P. THONNEAU1-2 
1 Equipe de Recherche en Fertilit6 Humaine (EA 3694), 
H6pital Paule de Viguier, 31059 Toulouse 
2 Service d'Urologie et d'Andrologie, HOpital Paule de 
Viguier, 31059 Toulouse 
3 CECOS (Centre de Conservation du Sperme), H6pital 
Paule de Viguier, 31059 Toulouse 
4 Corresponding author: HSpital Paule de Viguier, Groupe 
de Recherche en Fertilite Humaine (EA 3694), 330 av de 
Grande Bretagne, TSA 70034, 31059 Toulouse Cedex 9, 
France. walschaerts.m@chu-toulouse.fr 
Numerous international studies have observed constant and 
recent progression in the incidence rate of testicular cancer 
since the middle of the 20th century in industrialised countries. 
Objective : To find a predictive mathematical model of the time 
trend of testicular cancer incidence in the Midi-Pyrenees 
region of France. 
Design - Materials and Methods : Study of a consecutive 
series of 506 cases of testicular cancer occurring over a 20- 
year period (1980-1999) in the Midi-Pyrenees region. Patients 
were recruited in a standardised manner by the CECOS and 
the principal anti-cancer centres of the region, which made 
it possible to obtain a quasi-representative study population 
of testicular cancers in this area. Date of birth, year of tumour 
diagnosis and histological type were available for all patients. 
Incidence rates were standardised to the world population. An 
age-period-cohort model was adjusted using Poisson 
regression. 
306 
3 t / "  /tTGCT 15 .,~'/ 
J /  Non-seminoma 
/ -  
Year 
Age standardised (word population) incidence rates of testicular 
germ cell tumors (TGCTs) from 1980-1984 to 1995-1999 in 
Southern France. 
Results : Over the whole of the study period, we observed 
a marked increase in the incidence of testicular cancer (cf. 
figure), for both seminomas and non-seminatous germ-cell 
tumours (mean annual increase 5% and 8%, respectively). 
The incidence rate rose from 1.27 to 3.04 for 100 000 men 
between 1980 and 1999. The age-cohort submodel appeared 
to be predictive of the time trend of testicular cancer incidence 
and revealed the existence of a birth-cohort effect. 
Conclusion : The increased incidence of testicular cancer 
recorded in the Midi-Pyrenees region over the last 20 years 
reveals a birth-cohort effect similar to that observed in a 
number of European countries. This birth cohort effect is an 
argument in favour of the hypothesis now supported by 
numerous epidemiologists, that of environmental and/or 
occupational exposures to risk factors occurring early in life 
or even during the embryonic period. 
OR 11 
Androgen receptor gene CAG repeat length as a 
modifier of the association between persistent 
organohalogen pollutant exposure and semen 
characteristics 
A. GIWERCMAN a, L. RYLANDER b, 
A. RIGNELL-HYDBOM b, B.A.G. J~)NSSON b, 
H.S. PEDERSEN c, J.K. LUDWICKI f, V. LESOVOYg, 
V. ZVYEZDAY h, M. SPANO i, G.C. MANICARDIJ, 
D. BIZZARO k, E.C. BONEFELD-JORGENSEN d, 
G. TOFT e, J.P. BONDE e, C. GIWERCMAN a, T. TIIDO a, 
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b Division of Occupational and Environmental Medicine 
and Psychiatric Epidemiology, Lund University, Lund 
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Objectives : Exposure to Persistent Organohalogen Pollutants 
(POP) was suggested to impair male reproductive function. 
A gene-environment interaction has been proposed. No genes 
modifying the effect of POP on reproductive organs have yet 
been identified. We aimed to investigate whether the CAG and 
GGN polymorphisms in the androgen receptor (AR) gene 
modify the effect of POP exposure on human sperm 
characteristics. 
Design : Multi-centre prospective collection of biological 
material from partners of pregnant women (Greenland ; 
Kharkiv, Ukraine and Warsaw, Poland) and men from general 
population (Swedish fishermen). 
Materials and Methods : Semen and blood from 680 men 
(mean (SD) age 34 (10) years) from Greenland, Sweden, 
Warsaw (Poland) and Kharkiv (Ukraine) were collected. POP 
exposure was assessed by measuring serum levels of 2,2', 
4,4'5,5'-hexachlorobiphenyl (CB-153) and dichlorodiphenyl 
dichloroethene (p,p'-DDE). Semen characteristics (volume, 
sperm concentration, total count, proportion of progressively 
motile, morphology) and DNA Fragmentation Index (DFI). 
CAG and GGN repeat lengths were determined by direct 
sequencing of leukocyte DNA. 
Results : Taking into consideration the inter-centre differences 
in exposure levels and genotype distribution and including age 
and time of abstinence as confounders, a statistically significant 
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interaction was found between the CB-153 group and CAG 
repeat category in relation to sperm concentration and total 
sperm count (p=0.03 and p=0.01, respectively). For p,p'- 
DDE, in the European cohorts a significant interaction was 
found in relation to DFI (p=0.01). For CAG<20 sperm 
concentration and total sperm count were 35% and 42% 
lower, respectively, when the group with CB-153 exposure 
above median was compared to that below the median. DFI 
was 40% higher in high p,p'-DDE exposure group for CAG<21. 
Conclusions : The observed effect of POP exposure on 
sperm number was not seen when the genotype was not 
taken into consideration. This is the first study indicating ene- 
environment interaction in relation to semen parameters. AR 
CAG repeat length might modify the susceptibility of an 
individual to the adverse effects of POP exposure on semen 
quality. These findings need to be confirmed by other studies. 
Support : The study was supported by The European 
Commission to the 5th Framework Programme Quality of 
Life and Management of living resources, Key action four on 
environment and health, (Contract no. QLK4-CT-2001-00202), 
running 01.01.02-30.06.05. www.inuendo.dk. The Ukrainian 
part of the study was supported by a grant from INTAS 
(Contract no. 2001 2205). The Swedish part of the study has 
also been funded by the Swedish Medical Research Council 
(Grant No : 521-2004-6072) and the Swedish Research 
Council for Environment, Agricultural sciences and Spatial 
Planning. 
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Mechanisms underlying the age related fall in 
testosterone in men : results from the european 
male ageing study (EMAS) 
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(Sweden), 6 University of Turku (Finland), 7 Medical 
University of Lodz (Poland), 8 Medical University of Tartu 
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With the continuing rise in average life expectancy, care and 
prevention of disease/disability for the burgeoning elderly 
population have become priority targets for healthcare 
providers. A multi-centre longitudinal population cohort study 
was undertaken in Europe to investigate the relationships 
between age-related changes in hormones, their potential 
causes and the common clinical features of ageing in men. 
The present work aims to describe the changes in the 
reproductive ndocrine axis in ageing men, and to identify the 
underlying mechanisms and associated aetiological factors. 
A total of 3369 men aged 40 to 79 years were randomly 
recruited from the general population of eight cities 
(Manchester, Leuven, Tartu, Malmo, Szeged, Lodz, Florence 
and Santiago de Compostela). Total testosterone (TT), sex 
hormone binding globulin (SHBG), Luteinising hormone (LH) 
were measures in a central laboratory (Roche, Elecys E170) 
on a single fasting blood sample obtained before 11.00h. 
Free T (FT) was calculated from TT and SHBG. 
There was a significant age-related decline in TT and FT and 
an increase in LH and SHBG. 
Multiple linear regression, linear spline fitting and multinomial 
regression analyses were used to investigate the combined 
effects of age and other predictors. We identified four distinct 
loci of dysregulation in the feedforward/feedback mechanism 
in the reproductive endocrine axis, which simultaneously 
contributed to the overall pattern of circulating hormone 
changes with increasing age. Each of these mechanisms 
was associated with a specific factor/aetiology. 
Age : with increasing age, the testicular esponse to LH was 
impaired and compensated by increased LH The testicular 
dysfunction was amplified by the age-related increase in 
SHBG which resulted in a steeper decline in FT compared to 
TT. 
Obesity : (general and central) - high BMI and waist 
circumference were associated with low TT and FT. This was 
not accompanied by a compensatory rise in LH indicating 
the presence of hypothalamus/pituitary d sfunction. 
Co-morbidity : was associated with a more exaggerated 
rise in LH in men over the age of 70 indicating that testosterone 
feedback at hypothalamus/pituitary level was impaired or 
attenuated. 
Smoking : increased SHBG, total testosterone and LH with 
only a minimal change in free T. This was compatible with a 
primary effect on the liver which triggers the initial rise in 
SHBG followed by a resetting of the feedback at a higher 
level of LH to maintain normal free testosterone. 
We conclude that the age-related decline in circulating 
testosterone embraces a combination of specific 
dysregulations of hypothalamic-pituitary-testicular axis 
functions, each of which is associated with a distinct risk 
predictor. These mechanisms suggest that ageing is 
associated with compensated primary hypogonadism which 
develops into overt primary hypogonadism in the presence 
of comorbidity. Obesity on the other hand is associated with 
secondary (hypogonadotrophic) hypogonadism. Smoking is 
associated with increased TT due to elevated SHBG. 
email : abdelouahid.tajar@manchester.ac.uk. 
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Analysis of X-Y interactions in developing 
spermatids and characterisation of novel Y 
transcripts 
L. FERGUSON1, P.J.I. ELLIS 1, P.S. BURGOYNE 2, 
N.A. AFFARA1 
1 University of Cambridge Department of Pathology, 
England 
2 National Institute for Medical Research, England 
If268@cam.ac.uk 
Objective : A series of mouse lines with deletions on the Y 
chromosome display phenotypes ranging from 
teratozoospermia to complete infertility and grossly abnormal 
sperm heads, depending on the extent and location of the 
deletion. Some of the sub-fertile models display a sex ratio 
distortion towards females. We have extended our 
transcriptional analysis of these models to a comprehensive 
gone set and mapped a selection of genes whose expression 
is altered by the deletions. Our goal is to identify novel Y- 
linked genes contained within the deletions and elucidate 
downstream genetic mechanisms linking genotype to 
phenotype. 
Design / Materials and Methods : Array and quantitative RT- 
PCR data (1,2) was extended to wider gene-sets (a 36,000 
probe oligonucleotide set and the MmcDNAv1 chip.) Labelled 
testis cDNA from each of four Y deletion models was co- 
hybridised with labelled testis cDNA from wild-type mice of the 
same strain as a common control. Lowess normalisation and 
Z-score analysis was used to select significantly regulated 
genes. Expression profiles were confirmed using RT-PCR. The 
chromosomal location and copy number of novel (previously 
uncharacterised) transcripts of interest was determined via 
Southern blotting and confirmed by PCR analysis of genomic 
DNA from the deleted models. 
Figure 1 : MA plots of o/igonuc/eotide arrays for each Y 
deletion mode/. Red plots are significantly up or down regulated 
transcripts with a Z score > 1.28 (p = O. 1). 
Figure 2 : Genomic distribution of significantly up-regulated 
genes in the 100% Yq deletion model with respect to 
chromosomal gone density (ensembl) is biased towards the 
X chromosome. 
Results : Figure 1 : shows the significant differentially 
expressed transcripts (red) in the deletion models. Down- 
regulated Y-linked transcripts indicate loci deleted from the Y 
chromosome in the various models. Two down-regulated 
transcripts with genomic loci within the Sly (Sycp3 like Y- 
linked) gone family were identified, one of which is transcribed 
in anti-sense with respect to Sly. 
Other deregulated transcripts indicate downstream responses 
to the deletions. The array data highlighted the spermatid- 
specific up-regulation of X-linked genes in these deleted 
models (2). 
Figure 2 : shows the X chromosome bias of up-regulated 
genes in the 100% Yq deletion model. 
Southern blotting and BLAST searches were used to determine 
autosomal, X or Y linkage for novel unmapped transcripts, and 
to confirm the mapping of selected deregulated transcripts. 
Intriguingly, we discovered that an up-regulated transcript, 
the RIKEN cDNAAK006152, had a male specific locus (figure 
3a). This transcript was further mapped to Yp by PCR on 
genomic DNA from three mouse lines with deletions on Yp, 
indicating this gene is located either on telomeric Yp or within 
the centromeric Rbmy cluster (figure 3b). Transcription of the 
male specific locus AK006152 was shown by RT-PCR (figure 
3c) to be testis specific. 
Figures : 3a : Southern blot identifying male specific band. M 
= male, F = female. 
3b : Genomic PCR identifying the presence of the loci in all 
3 deletion models indicating a distal or proximal ocation on 
Yp common to all 3 models. 
3c : RT-PCR confirming expression of the transcript is testis 
specific. 
Southern blotting has also identified Y chromosome 
homologues of other up-regulated X-linked and autosomal 
genes (data not shown). 
Characterisation of deleted Yq linked genes may help in 
understanding the mechanism linking these deletions to the 
up-regulation of X-linked and Yp-linked genes and may be 
important in defining the phenotypes of these Y deletion 
models. (3) 
Conclusions : We can conclude that while there is an overall 
deregulation across the genome in the mouse Y chromosome 
deletion models, the number of genes up regulated on the X 
chromosome is significantly above average. This indicates a 
de-repression of X-linked genes (and some Yp-linked) as a 
consequence of these MSYq chromosomal deletions. 
We also conclude that several significantly down-regulated, 
uncharacterised transcripts in the Yq deletion models have Yq 
genomic loci and may have a role in the phenotypes of these 
models. 
Further studies of these novel Yq transcripts and the up- 
regulated X and Yq linked genes may provide insight into the 
mechanism of this proposed competitive interaction of the X 
and Y chromosomes in murine spermatogenesis. 
Support : 
1. Ellis P.J.I. et al. Hum. Mol. Gen., 2005, 14, 2705-2715. 
2. Ellis P.J.I. et al. Mol. Hum. Reprod., 2004, 10, 271-281. 




Germline hMLH3 variants in maturation arrest 
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Objective : To investigate whether hMLH3 gene mutations 
could be associated with meiosis impairment and consequently 
with human maturation arrest. 
Design : MutL homologue 3 is a member of a family of 
conserved proteins involved in DNA mismatch repair during 
replication and meiotic recombination. MLH3-deficient mice 
do not show microsatellite instability (MSI) and are sterile 
due to meiotic arrest (1). Hereditary nonpolyposis colorectal 
cancer (HNPCC) is commonly associated with defects of 
DNA MMR genes and MSI, but involvement of the human 
MLH3 gene in DNA MMR is currently under debate, as 
mutations have either been associated or found to be absent 
in HNPCC. However, there is no experimental evidence for 
a similar hMLH3 involvement in human meiosis. 
Material and Methods : Thirteen spermatogenic arrest 
patients studied for AZF/DAZ deletions were used for MLH3 
mutation analysis. Genomic DNA was isolated from the 
testicular biopsies using a DNeasy Tissue Kit (Qiagen). MSI 
status was determined using the HNPCC MIS test (Roche) 
and the BAT34 mononucleotide marker. The 12 coding exons 
and exon-intron boundaries of the hMLH3 gene were studied 
by DHPLC and sequencing (2,3). The primary spermatocyte 
stage arrest on the testicular biopsies was confirmed by FISH 
analysis of chromosomes 7/18/X/Y in isolated germ cells (4). 
Primary MA was diagnosed when no evident cause for the 
meiotic arrest was found. Secondary MA was used as a 
control group and was established with patients with conserved 
spermatogenesis in their past history, AZFc and DAZ1/DAZ2 
microdeletions (5) or hormonal disturbs like hypogonadotrophic 
hypogonadism. 
Statistics analyses were performed by using the difference 
between two proportions test (Statistica, vs. 5.1) with a 
probability value of 0.05 being regarded as significant. 
Results : All MA patients had a normal karyotype (46,XY) and 
none presented a personal or family history of HNPCC. Four 
out of 13 MA patients were considered primary MA and the 
remaining 9 cases secondary MA. MSI was negative for all 
patients. T2896C was detected in one secondary MA. C2531T 
combined with IVS9+66G->A were identified only in primary 
MA cases (3 of 4 patients, 75%; 95% C121.9-98.7%; p=0.003 
to secondary MA cases. Secondary MA cases revealed none 
of these changes (0 of 9, 0%; 95% CI 0-37.1%). The intronic 
variant IVS9+66G->A was identified in 5 of secondary MA 
cases (55.6%, 95% CI 22.7%-84.7%): two with past history 
of spermiogenesis, two with DAZI/DAZ2 microdeletions and 
one with panhypopituitarism. 
Conclusions : Our results suggest that primary spematogenic 
arrest is associated with two simultaneous (C2531T and 
IVS9+66G/A) hMLH3 variants. As isolated C2531T and 
IVS9+66G/A variants were previously described in several 
families with colorectal cancer as well as in controls, the 
presence of two simultaneous hMLH3 variants in patients 
with primary MA might represent an additive predisposing 
risk and be the cause of spermatogenic arrest. 
Support : 
1. Lipkin et al. (2002), 
2. Liu et al. (2003), 
3. Loukola et al. (2000), 
4. Sousa et al. (2002), 
5. Ferr~s et al. (2004). 
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Administration of estradiol stimulates 
proliferation of premieiotic germ cells and 
facilitates precocious maturation of Sertoli cells, 
promoting germ cell survival 
R. WALCZAK-J ED RZEJOWSKA, 
J. SLOWlKOWKA-HILCZER, K. MARCHLEWSKA, 
K. KULA 
Department of Andrology & Reproductive Endocrinology, 
Medical University of Lodz, Poland. 
E-mail:kkula@csk. umed.lodz.pl 
Estradiol may participate in spermatogenic onset but its roles 
in Sertoli and germ cell multiplication and apoptosis are not 
clear. 
Methods : Newborn male rats were daily injected between 
the 5th and 15th day of life with: 12.5 pg of estradiol benzoate 
(EB) or 7.5 IU of human purified FSH (hFSH) or EB+hFSH 
or solvents (control-C). On the 16th day blood was taken for 
hormone measurements and one testis for histology. 
Proliferation of germ and Sertoli cells were quantitatively 
evaluated by incidence of PCNA positive (+) and apoptosis 
by TUNEL+ cells. 
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Results : I) Blood level of testosterone was reduced to 25% 
ofC (p<0.01) after EB, to 49% ofC (p<0.01) after EB+hFSH 
and increased to 186% of C (p<0.05) after hFSH. Blood 
concentrations of prolactin increased to 1425% or 1265% of 
C after EB or EB+hFSH. (p<0.001). Blood triiodothyronine was 
slightly reduced by EB (84% of C, p<0.05) and by hFSH 
(90% of C, p<0.05) and not changed after EB+hFSH. EB did 
not influence blood levels of FSH or LH. 
II) In all groups first spermatogenesis progressed up to 
pachytene spermatocytes. Testes weight and tubule length 
were reduced by half of C after EB (p<0.001) and were 
doubled after hFSH or EB+hFSH (p<0.001). 
Seminal tubule diameter was reduced by EB (69.5+2.6 pm 
vs. 79.0+2.8 in C, p<0.001), was stimulated by EB+hFSH 
(94.1+1.9 jJm, p<0.001) and not changed by hFSH alone. 
The same concerned mean area of Sertoli cell nucleus. 
Similarly, while the formation of seminal tubules lumen 
increased by 3150% of C (p<0.01) after EB+hFSH, it was 
not affected by hFSH or EB alone, indicating that precocious 
completion of Sertoli cell maturation appeared after 
combination of estradiol and FSH with a possible involvement 
of prolactin. 
III) Incidence of PCNA+ germ cells was increased by all 
treatments: 90.8+3.7% of cells for EB; 92.5+2.1 for hFSH 
and 91.2+1.6 for EB+hFSH vs. 77.7+2.2 for C (p<0.001). 
Incidence of TUNEL+ germ cells was stimulated by EB to 
196% of C (p<0.05), not affected by hFSH, and inhibited to 
32% of C (p<0.05) after EB+hFSH. 
IV) Incidence of Sertoli PCNA+ cells was increased after 
hFSH to 420% of C (p<0.001) and reduced after EB or 
ER+hFSH to 25% of C (p<0.01). Incidence of Sertoli TUNEL+ 
cells was increased after EB to 967% of C (p<0.05) and not 
affected by hFSH or EB+hFSH. 
Conclusions : 
1) Administration of estradiol decreases testis maturation and 
secretion of testosterone but increases secretion of prolactin. 
2) Estradiol, FSH and possibly prolactin increase proliferation 
of germ cells and hence all hormones may be important for 
triggering spermatogenesis. 
3) Estradiol in synergism with FSH and possibly prolactin 
(but neither one of the hormone alone) induce acceleration 
of testis growth and Sertoli cell maturation, what in turn 
protects germ cells from apoptosis. 
4) While FSH stimulates, administration of estradiol inhibits 
proliferation of Sertoli cells facilitating the shift into 
nonproliferative functional phase of Sertoli cell development. 
OR 16 
Transition protein (TP) expression in spermatids 
detected in ejaculates from Infertile men 
Y. SOFFER, S. BECKER, L. YOGEV*, L. SHOCHAT, L. 
LEWlN, R. GOLAN 
Department of Human Mo/ecu/ar Genetics and 
Biochemistry Sack/er Schoo/ of Medicine, and */nstitute for 
the Study of Fertility, Te/ Aviv Sourasky Medica/ Center. 
Te/-Aviv University. 
Objective : TPs are DNA binding nuclear proteins found in 
spermatids during their differentiation. In rats, mice and 
humans TP2 appears first, shortly followed by TPI. Then 
protamine appears. The objective was to detect TP expression 
in seminal spermatids from infertile men. 
Design : Out of 60 human semen samples from infertile men 
submitted to flow cytometry (FC) using propidium iodide 
staining, 23 samples demonstrated immature haploid cells on 
FC histograms, with noncondensed immature lc DNA peaks. 
These samples were submitted to immunofluoresent staining 
of TP1 and TP2 and examined under confocal microscopy. 
Materials and Methods : Samples were smeared on slides 
covered with polylysine and incubated in citrate buffer (0.1 
M) at 900C for 10 minutes. Antibodies against transition 
proteins TP1 and TP2 (provided by Dr. W. S. Kistler) were 
added and incubated overnight, slides washed (3 times in 
Triton x-100 0.1%) and secondary antibody conjugated with 
FITC) was added for fluorescence and confocal microscopy. 
Sequential optical sections were prepared to demonstrate 
that TP expression was found inside the nuclei. 
Results : TP expression was observed in 12 samples out of 
23. In 9 samples, TP1 & TP2 were both expressed and in 3 
other samples, one of them only. Sequential optical sections 
using confocal microscopy demonstrated TP expression inside 
the nuclei. Flow cytometry performed on the semen samples 
revealed 4 peaks of haploid immature cells with various 
degrees of condensation. No clear relationship was found 
between degree of condensation and appearance of TP in the 
spermatids. 
Conclusion : TP expression was demonstrated inside the 
nuclei of spermatids in about half of samples of infertile human 
semen samples containing immature haploid cells indicating 
disturbance of differentiation i spermatids. Similarities between 
sperm defects found in TP's mutants animals and infertile 
patients (Shirley et al., 2006) highlight he importance of TP's 
expression research in infertility. In this study, the heterogeneity 
of our infertile patients group and its multifactorial etiology didn't 
allow us to correlate TP's expression with clinical data. 




The diagnostic role of Inhibin-13 in subfertile men 
and its correlation with testicular cytology 
P. POLICHRONOU, TH. MIKOS, D.G. GOULIS, 
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Obstetrics & Gynaecology, Aristotle University of 
Thessaloniki, Greece 
13 as independent parameters and FNA biopsy result as the 
dependent parameter evealed that only Inh-13 was a significant 
predictor of the FNA result (r2 = 0.289, p < 0,001). 
Conclusions : Basal serum lnh-~ seems to constitute an 
important diagnostic parameter in male subfertility, as it reflects 
both Sertoli cell reserve and testicular cytology. On the other 
hand, Sertoli cell reserve estimation, as estimated by EFSERT, 
does not seem to provide additional information for the 
diagnostic or the therapeutic approach of the subfertile male. 
Presenting author : Prof. J. Papadimas, 1st Department of 
Obstetrics & Gynaecology, "Papageorgiou" General Hospital, 
Periferiaki Odos, Nea Efkarpia, 564 03, Thessaloniki, Greece. 
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Objective : Inhibin-13 (Inh-~) is produced almost exclusively 
by Sertoli cells and controls FSH secretion through a negative 
feedback mechanism. The role of Inh-I~ as a diagnostic toot 
in male infertility is not fully elucidated. The aim of this study 
was to determine basal and stimulated Inh-J3 serum levels in 
fertile and infertile men and to correlate them with testicular 
cytology. 
Design : Prospective, cross-sectional, clinical study. 
Materials and Methods : Sixty-seven subfertile and 29 fertile 
men underwent clinical, sperm, basal hormonal and dynamic 
Sertoli-cell evaluation (EFSER Test: serum Inh-~ levels before 
and 24 h and 48 h after administration of 300 IU rhFSH 
subcutaneously). Genetic studies were applied as appropriate. 
Fifty-four of the subfertile men underwent testicular Fine 
Needle Aspiration biopsy (FNA). The final clinical diagnoses 
were: Idiopathic Non-Obstructive Azoospermia ( INOA- n = 
31,46%, 5 of them with Late-Onset Hypogonadism - LOH), 
varicocele (n = 14, 21%), cryptorchidism (n = 10, 15%) and 
other causes (n=12, 18%). 
Results : There was significant difference between subfertile 
and fertile men regarding the basal (55.8 + 51.2 vs 115.7 + 
54.0 pg/ml, respectively, p < 0,001) but not the stimulated 
Inh-13 levels (64.6 + 71.8 vs 69.7 + 23.6 pg/ml, p = NS at 24 
h and 63.3 + 79.2 vs 87.9 + 25.1 pg/ml, p = NS at 48 h). 
Patients with INOA and LOH, INOA only and cryptorchidism 
had the most severe Sertoli cell damage according to basal 
Inh-~ levels followed by varicocele. There was significant 
correlation between basal Inh-13 levels and FNA findings (r = 
0.488, p < 0.01) with lower Inh-13 levels corresponding to 
more severe cytology diagnoses (Sertoli Cell-Only Syndrome 
-SCOS and maturation arrest). We applied a Receiver 
Operative Characteristics (ROC) analysis for sperm retrieval 
in testicular FNA (i.e. cytological diagnoses of normal 
spermatogenesis and hypospermatogenesis). The area under 
the ROC curve was 0.663 for FSH and 0.725 for Inh-13, with 
a threshold level of 54 pg/ml having a sensitivity of 59% and 
a specificity of 86% for sperm retrieval. Multivariate stepwise 
logistic regression analysis having age, mean testicular 
volume, serum FSH, serum testosterone and basal serum Inh- 
Testosterone undecanoate is detected in seminal 
plasma and significantly increases serum 
dihydrotestosterone 
G. MITIOS, N. KAPOLLA, H. LASS*, E..KOUKKOU, 
S.C. NICOPOULOU, D.A. ADAMOPOULOS 
Endocrine Department, E/ena Venize/ou Hospital 
115 21 Athens 
* Bioanalytics, NV, Organon Oss and Organon 
Development GmbH, Waltrop, Germany 
Objective : Testosterone undecanoate (TU) has been used 
as a complimentary treatment o tamoxifen citrate in men 
with idiopathic oligozoospermia (1.O.) with satisfactory results. 
It has been postulated that TU through a dihydrotestosterone 
(DHT) promoting effect improves mainly epididymal 
environment and consequently the quality of spermatozoa. 
Design : To examine this possibility, TU has been administered 
(40 ng t.i.d.) to 18 healthy, normozoospermic volunteers for 
a week, with measurements of TU, total testosterone (TT), 
dihydrotestosterone (DHT), E2, SHBG, FSH, LH and PRL. 
Steroid hormones were measured in peripheral blood and 
on some occasions, in seminal plasma before and after TU 
administration. Moreover, steroid hormones were also 
measured in a small number of testicular tissue samples from 
5 unrelated men who also received TU before biopsy. 
Materials-Methods : A home made assay was employed for 
TU estimations and AutoDelphia assays for the remaining 
hormones. Measurements in seminal fluid and testicular tissue 
were made following standard extraction techniques. Analysis 
of the results was made following standard procedures. 
Results : TU had no effect on serum FSH (pre-: 6.0+0.7, 
post-: 5.1+2.5 U/mL), LH (pre-: 5.0+2.0, post-: 4.0+2.0 U/mL), 
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PRL (pre-: 5.1+3.7, post-: 4.0+2.0 U/mL), SHBG (pre-: 
30.0+13.8, post-: 26.0+12.2 nmol/L), TT (pre-: 4.88+1.63, 
post-: 4.24+1.69 ng/mL) and E2 (pre-: 27.6+8.0, post-: 26.9+5.4 
pg/mL). Following TU treatment, a marked increase of DHT 
was observed in peripheral blood (pre-: 0.46+0.20, post-: 
1.14+0.74 ng/mL, P<0.001, ratio: 0.41+0.15, increase: 248%) 
whereas no marked differences were noted for the remaining 
hormones. In seminal plasma, E2 and TT did not change 
after TU (E2:73.4+19.3 vs 70.2+24.3, TT: 0.6+0.1 vs 0.7+0.2) 
whereas DHT was not measured (by mistake). In the same 
fluid, TU was detectable in 6 of the 12 the samples assayed 
(11.1+8.0 ng/mL) and serum levels were comparable at 
12.7+7.6 ng/mL. The blood to seminal plasma ratio was 1.14 
signifying that the average seminal TU concentration was 
87.4% of that of peripheral blood. 
In testicular tissue extracts, high E2 and T values (E2: 
92.5+54.3 pg/mL, T: 48.8+16.3 ng/mL of extract dilution) were 
seen but TU was undetectable. 
Correlation analysis among the parameters examined showed 
that E2 and TU in serum and seminal plasma were significantly 
correlated both before and after treatment (pre : P<0.01,0.02 
post: 0.04, 0.02). Moreover, correlations were noted before 
and on TU between E2 and DHT in serum (P<0.02, 0.01) 
and seminal plasma (P<0.001 for both). 
Conclusions : By and large, it appears that TU administration 
increased markedly serum DHT levels, making a beneficial 
effect on epididymal and accessory gland function a distinct 
possibility. TU was measurable in a number of seminal plasma 
samples in a concentration close to that of peripheral blood, 
indicating a clear presence of this lipophylic agent in the 
relevant compartments of the male genital tract. These two 
findings may contribute to the understanding of TU's beneficial 
effect in sperm dynamics in I.O. patients. 
Support : T and DHT hormone assays were performed at 
Department of Bioanalytics, NV Organon, Oss The 
Netherlands, whereas TU and other hormones were analyzed 
at the Department of Bioanalytics, Organon Waltrop GmbH, 
Waltrop, Germany. The study was sponsored by NV Organon, 
Oss, The Netherlands. 
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Objective : The highly repetitive structure of the AZFc locus 
is a putative generator of Y diversity. We hypothesize that such 
genetic variability could account for the variable phenotypes 
detected in patients with partial AZFc deletions. To test this, 
we characterized with novel amplicon-specific markers the 
exact structure of the AZFc locus of men with partial AZFc 
deletions, in order to identify sequence rearrangements that 
could be associated to specific infertility phenotypes. 
Design : Gene and transcription unit copies previously mapped 
to AZFc amplicons were compared in silico in order to find 
amplicon specific nucleotide markers. Thus 7 novel amplicon- 
specific sequence family variants (SFVs) were designed and 
characterized in patients with partial AZFc deletions. These 
patients were selected after a previous STS screening of 
fertile and infertile men. Results were correlated to Y- 
haplogroup and (in)fertility phenotype. 
Materials and Methods : The available reference sequence 
copies of the PRY gene, TTY4 transcript and the grey 
amplicons were aligned and compared (ClustalW software, 
EMBL-EBI). Significant amplicon-specific nucleotide variants 
associated to differential endonuclease restriction patterns 
were selected, resulting in 7 new amplicon-specific SFVs: 
b2, gl, gr, b3, g2, g3 and b4. 
An initial screening for partial AZFc deletions was performed 
using a set of STSs (sY142, sYl197, sYl192, sY1291, sY1206 
and sY1201) in 299 idiopathic infertile men and 220 fertile men. 
Deletions were confirmed by Eco-RV DNA blotting using the 
49f probe. 
The AZFc ampliconic composition of the selected patients 
was characterized by sequencing all novel SFVs and by 
digestion profiling of previously described SFVs (DAZ-SNV 
I, DAZ-SNV II, sY586 and GOLY-SFV) and STS (Y-DAZ3). 
Y-haplogroup analysis of the patients having deletions was 
performed by typing 35 Y-SNPs. Statistical analysis was 
performed using SPSS v13.0 software. 
Results : Partial AZFc deletions were significantly more 
frequent in infertile men than in fertile controls : 16/299 (5.4%) 
vs. 3/220 (1.4%; P<0.05). Although by STS typing all of the 
19 deletions fit into the gr/gr profile, AZFc amplicon content 
in these patients varied significantly (14 different AZFc 
structures). Interestingly, the previously described gr/gr deletion 
mechanism could only be resolved in patients belonging to 
the R haplogroup (12/19). In this haplogroup, 7 rl/r3, 3 gl/g3 
and 2 rl/r4 deletions were characterized, as well as 4 gene 
conversions and 3 amplicon inversions. No correlation between 
AZFc structure and fertility was detected since the ampliconic 
compositions recorded for fertile men were also observed in 
oligo and azoospermic patients. 
Conclusions : The sequence rearrangement events operating 
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in the AZFc locus result in high sequence diversity. This is 
observed on a large scale in different haplogroups, and on a 
smaller scale inside each haplogroup. This diversity results 
in different substrates for deletion mechanisms, which are 
reflected in the diverse products of the gr/gr deletion resolved 
by the new markers. Our data indicate that partial AZFc 
deletions reflect the evolutionary history of that particular 
AZFc locus and that, although a fertility risk, correlation 
between a specificAZFc composition and infertility cannot be 
established, suggesting that AZFc genes are part of a 
multifactorial network. 
Support : Partially funded by Funda(~o para a Ci6ncia e 
Tecnologia: #SFRH/BD/16662/2004, and POCTI/ 
SAU/97/2001. 
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Aim of study : Partial deletions of the AZFc region 
(AZoospermia Factor) of the Y chromosome have been 
reported to be a significant risk factor for oligo-/azoospermia. 
Within the AZFc region, the DAZ (Deleted in AZoospermia) 
gene family is organized into two clusters with a variable 
number of copies with 99.9% homology. DAZ1/DAZ2 deletions 
have been found only in infertile men, as opposed to 
DAZ3/DAZ4 deletions found also in fertile men. The aim of 
the present study is to compare two methods for partial AZFc 
deletions detection: one based on STS (Sequence Tagged 
Sites) and the other one based on SNV (Single Nucleotide 
Variant) which allows to distinguish one copy from the 3 
others. 
Design and Location : In this retrospective study, first, we 
used previously published STS to screen infertile patients 
and controls in order to detect partial deletions of AZFc region. 
Secondly, we designed a method to detect SNV using DHPLC 
(Denaturing High Performance Liquid Chromatography). 
Materials and Methods : Patients : 850 infertile patients 
exhibiting a non-obstructive oligozoospermia or azoospermia 
and 72 normozoospermic fertile men have been analyzed. 
SNV: Detection of SNV-I, SNV-II, SNV-III (for DAZ4, DAZ1 and 
DAZ2 respectively) using DHPLC. DAZ3 is identified using a 
gene copy specific STS amplification. STS : Screening of 6 
STS: sYl161, sYl197, sYl191, sY1291, sY1206 and sY1201, 
in biplex. 
Results : STS : gr/gr deletions (corresponding to the absence 
of sY1291), b l/b3 deletions and b2/b3 deletions were found 
respectively in 38 men (4.8%), 2 men (0.3%) and 2 men 
(0.3%) with oligozoospermia or azoospermia. They were not 
detected in fertile normozoospermic men. SNV: 2.9% of 
patients and 0.5% of controls exhibited a DAZ1 deletion. 
4.9% of patients (38) but none normospermic exhibited a 
DAZ4 deletion. Surprisingly, DAZ2 and DAZ 3 "deletions" 
could be found both in controls and in patients (23% versus 
14.8%, and 10% versus 16%, respectively). 
Concordant results between the two methods were observed 
for 33 gr/gr deletions: 17 were DAZ1/2 deletions (57%) and 
16 were DAZ3/4 deletions (43%). The 5 others cases were 
gr/gr deletions according to STS with unexpected results with 
SNV analysis: one DAZ1/DAZ2/DAZ4 deletion, two with an 
isolated DAZ2 deletion, and two without any DAZ copy deletion. 
We also confirmed the two bl/b3 and the two b2/b3 deletions 
using SNV analysis. We consider that the SNV-III and Y- 
DAZ3 used for DAZ2 and DAZ3 are not useful, since they are 
absent in control patients (either these markers are not always 
present, or the absence of the corresponding copy has no 
consequence on fertility). Conversely, the absence of DAZ1 
and DAZ4, detected using SNV-II and SNV-I respectively, is 
predictive of infertility and correlates well to the STS detection 
results (exact Fisher's test p<10-3). No correlation with semen 
or clinical parameters could be found for infertile patients, 
neither with STS or SNV results. 
Conclusions : Study of SNV II and I, present in DAZ1 and 
DAZ4 respectively, by DHPLC, seems to be an easy method, 
completing the STS analysis. SNV analysis can bring additional 
information on the size and type of the partial AZFc deletions. 
Together with the Y haplogroups determination (in progress), 
STS and SNV combined analysis is needed to have a more 
accurate prognostic tool f r these small rearrangements of the 
Y chromosome. 
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Objective : Deletions of the AZoospermia Factor Regions 
(AZF) of the Y chromosome are associated with severe 
spermatogenic failure and represent the most frequent 
molecular genetic cause of azoospermia and severe 
oligozoospermia. The exact role of the candidate AZF genes 
is largely unknown due to both the extreme rarity of naturally 
occurring AZF gene specific mutations and the lack of 
functional assays. Only two cases of finely characterized and 
confirmed isolated AZF gene mutations have been reported 
to date. In both cases the mutations removed the USP9Y 
gene in the AZFa region.The associated phenotype in both 
cases was infertility due to severe impairment of the 
spermatogenesis. 
Here, we report the fine characterization of two different 
deletions in the USP9Y gene (one of the two candidate genes 
in the AZFa region), which have been transmitted through 
natural conception in two unrelated families. 
Materials and Methods : A total of 995 men affected by 
infertility have been screened forAZFa (USP9Y and DBY) and 
AZFb (elF1AY and HSFY) gene specific deletions in our 
laboratory. In addition, 350 normospermic men were screened 
for gene specific deletions and resulted not to be deleted for 
any of the two USP9Y markers. 
Since USP9Y is composed of 46 exons, we use two primer 
pairs, one mapping to exon 22 (GeneBank G54725), and 
another to exon 46 (GeneBank G34983). We used a number 
of additional gene specific markers to localize the breakpoints 
in patient two patients. The deletion junction has been then 
amplified using long range PCR, and the amplified products 
was sequenced by automatic sequencer (ABI PRISM 310, 
Applied Biosystems). 
Results : After the routine and gene specific screening we 
found two patients (1115 and A333) with partial USP9Y deletion 
(one of the two candidate genes in the AZFa region). The 
deletion in patient A333 removed the first 28 exons, whereas 
in patient 1115 the last 13 exons of the USP9Y gene. In patient 
1115, RT-PCR revealed the presence of the 5' end of USP9Y 
transcript and, as expected, the absence of its 3' end, 
suggesting the translation of a truncated protein. In patient 
A333 it is highly unlikely that the undeleted, 3' portion, of 
USP9Y was transcribed, as the deletion removed 28 kb of 
sequence 5' of the normal position of the first exon. The 
screening of the male relatives of both subjects enabled us 
to detect the transmission of deletion through natural 
conception in both unrelated families. The associated mild 
testicular phenotype (moderate oligoasthenotera- 
tozoospermia), in both cases, is in sharp contrast with that of 
the two previously reported infertile patients bearing a mutation 
of the same gene. 
Conclusions : In conclusion, to date the USP9Y gene has 
been considered as one of the major Y-linked spermatogenesis 
genes, based on both its position within the AZFa region and 
previous reports that correlated USP9Y mutation to severe 
spermatogenic failure and infertility. This view is now 
substantially changed since our findings clearly demonstrate 
that during human spermatogenesis, USP9Y is more likely a 
fine tuner which improves efficiency rather than a provider of 
an essential function. More importantly, the observed natural 
conceptions suggest that the protein is not required for the 
final sperm maturation process or for the acquisition of sperm 
fertilizing ability providing a new perspective on the role played 
by the USP9Y gene in male fertility. 
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Objective : Prostate gland secretions are rich in prostasomes, 
vesicles known to play an important role in male fertility. 
Prostasomes have an unusually high concentration of 
cholesterol relative to phospholipids (2:1 a compared with 
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1:1 found in plasma membranes). However, their mechanisms 
of action are still poorly understood. 
In the laboratory, Picherit et al. have reported that human 
spermatozoa incubated for 3 hours with cyclodextrine (an 
acceptor of cholesterol) exhibited a strong correlation between 
the degree of tyrosine phosphorylation of a 107 KDa protein 
and ionophore A23187-induced acrosome reactions. 
It is known that loss of cholesterol from sperm membranes 
occurs during capacitation. Since evidence indicates that 
prostasomal molecules, especially cholesterol, can be 
transferred to sperm under certain conditions, we hypothesized 
that transfer of cholesterol to sperm membranes could affect 
some spermatozoa properties. Therefore, we investigated 
the effect of prostasomes on 1) the tyrosine phosphorylation 
of a 107KDa protein band, 2) sperm lipid profile. 
Materials and Methods : Human spermatozoa were selected 
by Percoll density centrifugation and incubated for 3 hours at 
37oC under an atmosphere of 5% CO2 in air, in the absence 
or presence of increasing concentrations of prostasomes. 
Quantities of prostasomes used for experiments were 
expressed in terms of cholesterol (0.3 nmol to 45 nmol of 
cholesterol / 100 pl of incubation medium). After incubation 
either Western blotting analysis or HPTLC were performed. 
Results : The cell viability measured after 3 hours incubation 
in the absence or presence of prostasomes was not modified 
compared with the sperm population viability measured before 
incubation. 
We observed that tyrosine phosphorylation of the 107KDa 
protein band was inhibited when sperm were incubated with 
increasing concentrations of prostasomes; the differences 
relative to untreated controls were significant for 30 and 45 
nmol of cholesterol per 100 pl of incubation medium. We also 
noted a significant increase in the amount of cholesterol and 
the main classes of phospholipids. These enrichments were 
dose dependent. 
Conclusion : We concluded that prostasomes in vitro are 
capable of inhibiting events (tyrosine phosphorylation) known 
to be activated during the capacitation process. The changes 
in the lipid composition after 3 hours incubation, and more 
specifically enrichment in cholesterol could be responsible of 
this inhibitory effect. These results suggest that prostasomes 
could in vitro maintain human sperm in a non capacitated 
state and partly explain the anti-capacitating properties of 
seminal plasma. Further in vitro studies are required to 
complement his work. 
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Human mitochondrial DNA (mtDNA) encodes 13 polypeptides 
of the electron transfer chain, the apparatus that is responsible 
for the generation of ATP through the process of oxidative 
phosphorylation. The integrity of the mitochondrial genome 
is particularly important in those cells with high energy 
demands, such as sperm. Its replication is dependent on 
nuclear-encoded factors, including DNA Polymerase Gamma 
(POLG) and mitochondrial transcription factor A (TFAM). 
POLG is the DNA polymerase specific to mtDNA replication. 
TFAM activates mtDNA transcription and thus replication, 
and is thought to be a regulator of mtDNA copy number. 
Down-regulation of TFAM was proposed to cause the 10-fold 
reduction in mtDNA copy number during spermiogenesis. 
Furthermore, low levels of expression of either of these two 
proteins have been associated with mtDNA-depletion 
syndromes. 
The aim of this study was to investigate the significance of 
the expression of POLG and TFAM in the quality of human 
sperm and to determine whether these two factors influence 
sperm mtDNA content. We have analysed 93 sperm samples 
from men attending a Portuguese infertility clinic and 
categorized them into three groups, as evaluated according 
to the World Health Organization Guidelines (1999) : i) 
normozoospermic ; ii) samples with one or two abnormal 
semen parameters; and iii) oligoasthenoteratozoospermic 
(OAT). POLG and TFAM expression was evaluated using 
immunocytochemistry and Western Blotting. MtDNAcontent 
was determined in 42 samples by the ratio of mtDNA copies 
to the nuclear-encoded Beta-Globin gene, through real-time 
quantitative PCR. POLG and TFAM expression was Iocalised 
to the midpiece of mature sperm. 
The percentage of those sperm expressing these proteins 
was significantly lower in OAT than in normozoospermic 
samples (P < 0.01 for POLG, P < 0.05 for TFAM). The mean 
mtDNA copy number for human sperm was determined at 21.6 
+ 5.8. However, in contrast to POLG and TFAM levels, the 
mtDNA content was significantly higher in OAT samples (46.7 
+15.0) than in normal samples (6.8 + 1.8, P < 0.01) and in 
samples with 1 or2 defects (11.3 +4.5, P < 0.05). Indeed and 
paradoxically, a negative correlation was found between 
mtDNA copy number and the percentage of sperm expressing 
POLG (R = -0.582, P <0.001). 
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We propose that the reduction in mtDNA content observed 
in normal samples reflects normal spermiogenesis. The high 
number of mtDNA copies associated with OAT samples may 
reflect one of many outcomes arising from defective 
spermiogenesis. We further propose that, in normal samples, 
mature sperm increase their levels of POLG and TFAM 
expression in an attempt o compensate for the low mtDNA 
content. However, this mechanism appears to be ineffective 
due to the persistence of low copy number. 
In conclusion, tight regulation of nucleo-mitochondrial 
interactions might be essential for the effective completion of 
spermiogenesis and subsequent sperm function. 
A.A is supported by FCT Portugal (SFRH/BD/12665/2003). 
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(111/BIO/50/2005) and by British Heart Foundation (PG/04/117). 
of AKAP3 which results in PKA recruitment and activation in 
sperm tails (Luconi et al, J Cell Sci, 2004). Among TKs 
activated during capacitation, p60src has been identified for 
the first time. Interestingly, PKA contributes to stimulate TKs, 
thus a positive loop is established between tyrosine 
phosphorylation and PKA activity. At longer time, the relative 
importance of PKA declines and motility seems to be mainly 
maintained by TKs, as demonstrated by the absence of effect 
of H89 at 2 hour capacitation. 
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Although the role of protein phosphorylation/dephosphorylation 
in regulation of sperm functions is well known, the precise 
timing of activation and reciprocal function of protein kinase 
A (PKA) and tyrosine kinases (TKs) in the development and 
maintenance of sperm motility and capacitation is still unclear. 
By western blot analysis of human sperm using PY20 antibody 
directed against tyrosine phosphorylated protein motif, we 
demonstrated that during sperm capacitation tyrosine 
phosphorylation is the first signal to be activated which is 
responsible of the time-dependent increase in sperm motility. 
Blocking TKs from the beginning of capacitation results in a 
significant inhibition of sperm motility parameters evaluated 
by CASA, associated by a reduction of PKA activity, evaluated 
using an antibody against PKA activated substrates. On the 
contrary, inhibition of PKA by H89 slightly affects sperm motility 
and tyrosine phosphorylation but only at the very first step of 
capacitation (30 min), whereas such processes are unaffected 
at longer time (2h-3h), suggesting a precise timing in regulation 
of sperm motility. In the model we propose, in fact, TKs are 
immediately activated when capacitation starts and act 
upstream of PKA, probably through tyrosine phosphorylation 
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